Subscriptions to Suit Your Needs
Beacon’s customizable, modular, cloud-based software-as-a-service platform enables you to personalize drug development data and analysis so that it seamlessly integrates into your daily workflows.
Our approach allows you to tailor Beacon to your needs. From a single-user licence for one module to enterprise-wide for all Beacon modules, we have solutions that help you optimize your budget.
Only pay for the data that is critical to your business and line of research.
Our solutions are designed to enable multinational pharma, biotech, academics, CROs and anyone with a vested interest in the progress and development of new therapies to conduct:
- Target discovery and analysis
- Drug candidate screening and benchmarking
- Market entry and exit strategy
- Trial design and development
- Translational science analysis
Tailor your package from the following options:
Covering all Antibody Drug Conjugates (ADCs), Small Molecule Drug Conjugates (SMDCs), Protein Drug Conjugates (PDCs), Immunotoxins and more
Covering all engineered and non-engineered immune cell therapies, including CAR-T, TCR, NK, TILs, Gamma-Delta T Cells and more
Covering all Bi- and Multi-Specific Antibodies, Antibody Fragments, Augmented Antibodies and more
Beacon Cancer Vaccine provides the solution you need to master the prophylactic and therapeutic cancer vaccines field.
Covering all Immune Checkpoint Combination Trials and Immune Checkpoint Modulators in development across 27 different checkpoint targets
Covering all cytokines and drugs that target a cytokine or its immediate receptor belonging to the Interleukins, Interferons, Colony-stimulating factors, Transforming growth factor β, Tumour necrosis factor and Chemokines families.
Beacon DDR steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the DDR field.
From gene-editing technologies, novel delivery systems, and a variety of genetic materials being used- Beacon Gene Therapy steps into the field to give drug developers a precise and detailed view of how the gene therapy landscape looks.
Covering all therapeutics aimed at treating immune-mediated diseases – Beacon Immune Tolerance provides drug developers with detailed views of the expanding immune tolerance landscape.
Covering all pharmaceutical grade microbiome-based therapeutics across all disease indications – Beacon Microbiome provides drug developers with detailed views of the expanding microbiome landscape.
From capturing viral family and strains to understanding any genetic modifications – Beacon Oncolytic Viruses steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the Oncolytic Virus field.
Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space.
Beacon TPD provides the solution you need to master the targeted protein degradation field.
What our customers say
“Beacon is helpful when I need data on the fly. I find it valuable to be able to go through the platform quickly and see the up to date status of ADCs and targets”
Chief Development Officer
BioPharma Consulting
About Beacon
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals, tracking targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
See our clinical trials and drug
database solutions in action
Want to find out more about our data
and analysis?
